You have 9 free searches left this month | for more free features.

Primary Mitochondrial Myopathy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Mitochondrial Myopathy Trial in United States (Bocidelpar, Placebo)

Recruiting
  • Primary Mitochondrial Myopathy
  • Phoenix, Arizona
  • +13 more
Jan 21, 2023

Primary Mitochondrial Myopathy Trial in Australia, Spain, United Kingdom (REN001)

Recruiting
  • Primary Mitochondrial Myopathy
  • Adelaide, South Australia, Australia
  • +4 more
Apr 7, 2022

Primary Mitochondrial Disease Trial in United States (elamipretide)

Terminated
  • Primary Mitochondrial Disease
  • San Diego, California
  • +3 more
Nov 19, 2021

Primary Mitochondrial Disease Trial in Philadelphia

Recruiting
  • Primary Mitochondrial Disease
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Apr 25, 2022

    Primary Mitochondrial Myopathy Trial in Worldwide (elamipretide, comparator, elamipretide open label treatment)

    Terminated
    • Primary Mitochondrial Myopathy
    • elamipretide
    • +2 more
    • La Jolla, California
    • +26 more
    Jan 16, 2022

    Primary Mitochondrial Myopathy Trial in Worldwide (REN001, Placebo)

    Recruiting
    • Primary Mitochondrial Myopathy
    • La Jolla, California
    • +42 more
    Dec 7, 2022

    Primary Mitochondrial Disease Trial in Germany, Italy (OMT-28)

    Recruiting
    • Primary Mitochondrial Disease
    • Bonn, Germany
    • +5 more
    Aug 3, 2023

    Primary Mitochondrial Myopathy Trial in London, Newcastle Upon Tyne (REN001)

    Terminated
    • Primary Mitochondrial Myopathy
    • London, United Kingdom
    • +1 more
    Jul 14, 2020

    Mitochondrial Myopathies, Mitochondrial Diseases Trial (Nanosensor)

    Recruiting
    • Mitochondrial Myopathies
    • Mitochondrial Diseases
    • Nanosensor
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Nov 30, 2022

    Primary Mitochondrial Myopathies Trial in Madrid

    Not yet recruiting
    • Primary Mitochondrial Myopathies
      • Madrid, Spain
        Hospital Universitario 12 Octubre
      Dec 7, 2022

      Mitochondrial Myopathy Trial in Rochester (Nicotinamide Riboside, Placebo)

      Not yet recruiting
      • Mitochondrial Myopathy
      • Nicotinamide Riboside
      • Placebo
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 17, 2023

      Genomic Profiling of Mitochondrial Disease - Imaging Analysis

      Recruiting
      • Mitochondrial Myopathies
      • +4 more
        • Rochester, Minnesota
          Mayo Clinic
        Jul 12, 2022

        Primary Mitochondrial Disease Trial in Copenhagen, Cambridge (KL1333, Placebo)

        Recruiting
        • Primary Mitochondrial Disease
        • Copenhagen, Denmark
        • +1 more
        Jan 27, 2023

        Mitochondrial Myopathies, Mitochondrial Diseases Trial in Philadelphia (diagnostic test, device, drug)

        Not yet recruiting
        • Mitochondrial Myopathies
        • Mitochondrial Diseases
        • Cardiopulmonary Exercise Testing
        • +4 more
        • Philadelphia, Pennsylvania
          Children's Hospital of Philadelphia
        Jan 3, 2023

        Mitochondrial Dysfunction in Primary Progressive Multiple

        Recruiting
        • Multiple Sclerosis
          • Milan, MI, Italy
          • +1 more
          Aug 29, 2023

          Mitochondrial Diseases, Mitochondrial Myopathies, Mitochondrial Encephalomyopathies Trial in Philadelphia (Promoting Resilience

          Recruiting
          • Mitochondrial Diseases
          • +4 more
          • Promoting Resilience in Stress Management (PRISM)
          • Clinical-focused narrative (CFN)
          • Philadelphia, Pennsylvania
            Children's Hospital of Philadelphia
          Sep 12, 2023

          Primary Mitochondrial Disease Trial in United States (Elamipretide, Placebo)

          Completed
          • Primary Mitochondrial Disease
          • San Diego, California
          • +3 more
          Jul 6, 2020

          Patients With Mutations in SEPN1 (SELENON) or LAMA2

          Recruiting
          • MDC1A
          • SELENON-related Myopathy
          • No intervention
          • Nijmegen, Gelderland, Netherlands
            Radboudumc
          Apr 27, 2022

          Oxidative Capacity and Exercise Tolerance in Ambulatory SMA

          Completed
          • Spinal Muscular Atrophy Type 3
          • Mitochondrial Myopathy
            • New York, New York
              Columbia University Medical Center
            Mar 7, 2022

            Muscle CrCest Muscle Phenotyping in Primary Mitochondrial

            Recruiting
            • Mitochondrial Diseases
            • Creatine Chemical Exchange Saturation Transfer (CrCEST) Imaging Sequence
            • Philadelphia, Pennsylvania
              Children's Hospital of Philadelphia
            Jul 13, 2022

            MItochondrial Myopathies Trial in Denmark, United States (Omaveloxolone capsules, 2.5 mg, omaveloxolone capsules, 5 mg,

            Completed
            • MItochondrial Myopathies
            • Omaveloxolone capsules, 2.5 mg
            • +7 more
            • Los Angeles, California
            • +8 more
            Sep 15, 2021

            Myopathy; Primary Trial in Lubbock (Placebo, Low GG, High GG)

            Not yet recruiting
            • Myopathy; Primary
            • Placebo
            • +2 more
            • Lubbock, Texas
              Texas Tech University Health Sciences Center
            May 10, 2022

            MITOMICS :Multi-OMICS Approach for Diagnosis of Mitochondrial

            Not yet recruiting
            • Mitochondrial Diseases
            • diagnosis of mitochondrial myopathy
            • (no location specified)
            Jun 4, 2021

            Mitochondrial Myopathies Trial in Helsinki (Niacin)

            Completed
            • Mitochondrial Myopathies
            • Niacin
            • Helsinki, Finland
              University of Helsinki
            Jan 21, 2021

            Mitochondrial Disease, Neurology, Myopathy Trial run by the NHGRI (EPI-743, Placebo)

            Completed
            • Mitochondrial Disease
            • +2 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Mar 19, 2021